Sandbox Reserved 713: Difference between revisions

No edit summary
No edit summary
Line 17: Line 17:


As the interaction between copper ion and APP can modulate the production of Aβ peptide <ref name="Molecular"> PMID:18030462 </ref> and also the progression of Alzheimer disease, structural studies of the Cu-binding Domain of this protein give a lot of information for the development of novel therapeutics.
As the interaction between copper ion and APP can modulate the production of Aβ peptide <ref name="Molecular"> PMID:18030462 </ref> and also the progression of Alzheimer disease, structural studies of the Cu-binding Domain of this protein give a lot of information for the development of novel therapeutics.


=='''Structure'''==
=='''Structure'''==


<Structure load='2fkl' size='450' align='left' background='none' scene='' caption='[[2fkl]]'/>
<Structure load='2fkl' size='400' align='left' background='none' scene='' caption='[[2fkl]]'/>
The three dimensional structure of the Cu-Binding Domain was first determined by resonance multidimensional NMR spectroscopy <ref name="MolecularI"> PMID:12611883 </ref>. More recently, the determination of the crystallographic structure permits to define the molecular interaction between the Cu-Binding Domain and copper.<ref name="Molecular" />
The three dimensional structure of the Cu-Binding Domain was first determined by resonance multidimensional NMR spectroscopy <ref name="MolecularI"> PMID:12611883 </ref>. More recently, the determination of the crystallographic structure permits to define the molecular interaction between the Cu-Binding Domain and copper.<ref name="Molecular" />


Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA, Andréa Mc Cann